Acute Kidney Injury, Hypercalcemia and a Lung Mass
Surjit Tarafdar, Yvette Mikaheal, Basim Alqutawneh, Lukas Kairaitis
Abstract
Surjit Tarafdar, Yvette Mikaheal, Basim Alqutawneh, Lukas Kairaitis
Abstract
Plasma cell dyscrasias are characterized by neoplastic proliferation of a single clone of plasma cells typically producing a monoclonal immunoglobulin. Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma) or more commonly as multiple lesions (multiple myeloma). Plasmacytomas can be present at the initial diagnosis of multiple myeloma or develop later during the course of the disease. When plasmacytoma is associated with 10 percent or more clonal plasma cells in the bone marrow, the diagnosis is considered to be multiple myeloma rather than solitary plasmacytoma. While solitary plasmacytomas are treated with radiotherapy, multiple myeloma is treated with chemotherapy.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Plasma cell dyscrasias are characterized by neoplastic proliferation of a single clone of plasma cells typically producing a monoclonal immunoglobulin. Plasma cell neoplasms can present as a single lesion (solitary plasmacytoma) or more commonly as multiple lesions (multiple myeloma). Plasmacytomas can be present at the initial diagnosis of multiple myeloma or develop later during the course of the disease. When plasmacytoma is associated with 10 percent or more clonal plasma cells in the bone marrow, the diagnosis is considered to be multiple myeloma rather than solitary plasmacytoma. While solitary plasmacytomas are treated with radiotherapy, multiple myeloma is treated with chemotherapy.
Key concepts: Multiple myeloma, Plasmacytoma, Plasma cell neoplasm, Plasma cell, Plasma cell dyscrasia, Dyscrasia, Medicine, Bone marrow